Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
1. Adults with severe COVID-19 treated with remdesivir had numerically faster time to clinical improvement compared to controls, but the difference was not statistically significant
Evidence Rating: 1 (Excellent)
Months into declaration of COVID-19 as a pandemic, there still remains...